Institutional investors purchased a net $1.5 million shares of PCYC during the quarter ended December 2014. This may signal that the smart money is gaining interest in this company as the 78.85% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CANDRIAM BELGIUM SA Bought 29.2 Thousand shares of Pharmacyclics Inc
NEXT FINANCIAL GROUP, INC. Bought 12.4 Thousand shares of Pharmacyclics Inc
QUOTIENT INVESTORS LLC Bought 10.9 Thousand shares of Pharmacyclics Inc